Table 2.
Type of therapy | Patients, n |
---|---|
Cytotoxic | |
5-fluorouracil | 24 |
Oxaliplatin | 7 |
Irinotecan | 13 |
Oxaliplatin and irinotecan | 2 |
Unknown | 2 |
Anti-angiogenic | |
Bevacizumab | 14 |
None | 8 |
Unknown | 2 |
Treatment on clinical trial | 2 |
Lines of systemic therapy, n | |
1 | 23 |
2 | 1 |